Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 356 followers.

#elderly #gliomas Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma. https://t.co/dqqxXQnQDB

31 Jan 2019

Reply Repost Favourite